NAPLEX (North American Pharmacist Licensure Examination) Practice Exam

Disable ads (and more) with a membership for a one time $4.99 payment

Ace your North American Pharmacist Licensure Examination (NAPLEX) with our comprehensive practice test. Features include interactive flashcards, multiple-choice questions, with detailed hints and explanations. Fast-track your pharmacy career today!

Practice this question and more.


What monitoring is essential after initiating treatment with a calcimimetic in a CKD patient?

  1. Hemoglobin levels

  2. Blood sugar levels

  3. Calcium levels

  4. Urine output

The correct answer is: Calcium levels

It is essential to monitor calcium levels after initiating treatment with a calcimimetic in a CKD patient because calcimimetics work by reducing the levels of parathyroid hormone, which can result in a decrease in blood calcium levels. Hemoglobin levels may also be important to monitor, but this is not the most essential parameter to keep an eye on. Blood sugar levels and urine output are not directly affected by calcimimetic treatment and therefore do not need to be specifically monitored for changes.